mitsubishi tanabe pharma corporation

GHIT Announces Ten New Funding Partnerships

The Global Health Innovative Technology Fund has ten new funding partners that include major global pharmaceutical and biotechnology companies.

GHIT Fund Deepens Support For Schistosomiasis & Leishmaniasis

An additional US$11 million has been committed to developing diagnostics and drugs for neglected tropical diseases.

Medicago Inc And Mitsubishi Tanabe Pharma Enter Into Vaccine Alliance

Medicago Inc. has entered into a strategic alliance with Mitsubishi Tanabe Pharma Corporation to develop and commercialize at least three new vaccines together.

Lundbeck Launches Antidepressent Lexapro In Japan

Lexapro® - the most prescribed branded antidepressant in the world - has been launched in Japan by H. Lundbeck A/S and its partners, Mochiba and Mitsubishi Tanabe Pharma.